Clinical Trials Directory

Trials / Sponsors / Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Industry · 14 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery
Pain
Phase 32025-04-01
Not Yet RecruitingA Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery
Pain
Phase 22025-04-01
RecruitingSafety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
Insomnia Disorder
Phase 32025-03-25
Active Not RecruitingA Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
Insomnia, Central Nervous System
Phase 12024-08-31
Active Not RecruitingA Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects
Insomnia
Phase 12024-08-22
Active Not RecruitingPharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impair
Insomnia, Renal Impairment
Phase 12024-06-03
CompletedPharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment
Insomnia, Hepatic Impairment
Phase 12024-03-22
Active Not RecruitingA Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain
Pain
Phase 22023-12-26
RecruitingA Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors
Solid Tumor
Phase 12023-08-11
CompletedA Phase 1 Study of YZJ-4729 Tartrate Injection in Healthy Chinese Subjects
Postoperative Analgesia
Phase 12022-10-12
RecruitingSafety and Efficacy Study of YZJ-1139 in Insomnia Disorder
Insomnia Disorder
Phase 32021-12-17
CompletedSafety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder
Insomnia Disorder
Phase 22019-08-04
CompletedPK/PD Study of YZJ-1139
Insomnia
Phase 12019-03-07
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in
Insomnia
Phase 12017-12-01